STEPHEN DIAMANTONI: Open Payments
NPI 1831240100 · LANCASTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,294 in 209 payments from 31 companies in 2025. Trend: 2023 $3,934 · 2024 $4,115 · 2025 $4,294
Food & beverage: $4,294
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 30 | $686 |
| ABBVIE INC. | 32 | $602 |
| Novo Nordisk Inc | 23 | $486 |
| Lilly USA, LLC | 17 | $311 |
| Supernus Pharmaceuticals, Inc. | 11 | $283 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $253 |
| PFIZER INC. | 10 | $189 |
| Astellas Pharma US Inc | 7 | $166 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $155 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $152 |
Products named: AIRSUPRA, QULIPTA, Qelbree, Kerendia, JARDIANCE, Wegovy, MOUNJARO, Veozah.
Industry payments across PA — which companies pay providers there.
